Loading...
Prostate Cancer Library
A Phase 3, Randomized, Double-blind, Placebo-Contr
-
Texas Assisted Living Library
Home
Browse
Contribute
Submit
About Us
Contact
/
Home
/
Prostate Cancer Treatment Options
/
Ongoing Clinical Trials for Prostate Cancer
/A Phase 3, Randomized, Double-blind, Placebo-Contr
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Ace...
Votes:35
Comments:0
Study Title: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Fai
READ MORE
http://www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.4343613/k.5...
A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
Alternative Remedies Library
,
Stem Cells Library
Sites of Interest
Arthritis Library
New Items
-
Subscribe
Hematology Library
Autism Library
Search
Search
Search
Search
Login
Privacy Policy